chr3-123612296-T-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_053025.4(MYLK):​c.*1809A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.303 in 152,564 control chromosomes in the GnomAD database, including 10,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 10377 hom., cov: 32)
Exomes 𝑓: 0.087 ( 1 hom. )

Consequence

MYLK
NM_053025.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.266
Variant links:
Genes affected
MYLK (HGNC:7590): (myosin light chain kinase) This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]
MYLK-AS1 (HGNC:42440): (MYLK antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 3-123612296-T-C is Benign according to our data. Variant chr3-123612296-T-C is described in ClinVar as [Benign]. Clinvar id is 342823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.6 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYLKNM_053025.4 linkuse as main transcriptc.*1809A>G 3_prime_UTR_variant 34/34 ENST00000360304.8
MYLK-AS1NR_038266.2 linkuse as main transcriptn.290-17198T>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYLKENST00000360304.8 linkuse as main transcriptc.*1809A>G 3_prime_UTR_variant 34/345 NM_053025.4 P4Q15746-1
MYLK-AS1ENST00000485162.5 linkuse as main transcriptn.261-17198T>C intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.303
AC:
46110
AN:
152008
Hom.:
10345
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.587
Gnomad AMI
AF:
0.0877
Gnomad AMR
AF:
0.350
Gnomad ASJ
AF:
0.238
Gnomad EAS
AF:
0.616
Gnomad SAS
AF:
0.324
Gnomad FIN
AF:
0.0931
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.291
GnomAD4 exome
AF:
0.0868
AC:
38
AN:
438
Hom.:
1
Cov.:
0
AF XY:
0.106
AC XY:
28
AN XY:
264
show subpopulations
Gnomad4 AFR exome
AF:
1.00
Gnomad4 FIN exome
AF:
0.0845
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.304
AC:
46200
AN:
152126
Hom.:
10377
Cov.:
32
AF XY:
0.304
AC XY:
22592
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.587
Gnomad4 AMR
AF:
0.351
Gnomad4 ASJ
AF:
0.238
Gnomad4 EAS
AF:
0.617
Gnomad4 SAS
AF:
0.324
Gnomad4 FIN
AF:
0.0931
Gnomad4 NFE
AF:
0.135
Gnomad4 OTH
AF:
0.294
Alfa
AF:
0.185
Hom.:
5540
Bravo
AF:
0.336
Asia WGS
AF:
0.450
AC:
1566
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Aortic aneurysm, familial thoracic 7 Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJul 03, 2018- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
3.7
DANN
Benign
0.86

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6438804; hg19: chr3-123331143; COSMIC: COSV60607056; COSMIC: COSV60607056; API